Martin Amark, CEO, Xbrane Biopharma 00:00:00

Share On Facebook Share On Twitter

Xbrane BioPharma (STO:XBRANE) CEO Martin Amark sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Sweden-based biopharmaceutical company is developing a variety of biosimilars, on the basis of the attractiveness of the market, competitive situation, and the competitive advantage Xbrane can have on the basis of its technological platform and capabilities.

Recent Videos